{"entity":{"type":"insider","cik":"0001604874","url":"/insider/0001604874","json_url":"/insider/0001604874.json","name":"Latham John A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":27,"first":"2015-01-28","last":"2018-11-05","span_basis":"filed_date"},"name_variants":[{"name":"Latham John A","source":"filing","n_filings":27,"first_seen":"2015-01-28","last_seen":"2018-11-05"}],"transactions":[{"id":6426844,"accession":"0001209191-18-057261","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-057261","line_url":"/filing/0001209191-18-057261","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25002.0,"shares_display":"25,002","price_per_share":13.422477905767538,"price_display":"13.42","price_state":"stated","total_value":335588.7926,"total_display":"335,588.79","total_whole":"335,589","shares_owned_after":245012.0,"shares_owned_after_display":"245,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-05","scope":"insider","n_lines":2},{"id":6001262,"accession":"0001209191-18-054084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-054084","line_url":"/filing/0001209191-18-054084","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":15.440839525581023,"price_display":"15.44","price_state":"stated","total_value":386005.5473,"total_display":"386,005.55","total_whole":"386,006","shares_owned_after":250247.0,"shares_owned_after_display":"250,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-03","scope":"insider","n_lines":2},{"id":6047723,"accession":"0001209191-18-049870","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-049870","line_url":"/filing/0001209191-18-049870#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":17.9879,"price_display":"17.99","price_state":"stated","total_value":449679.5121,"total_display":"449,679.51","total_whole":"449,680","shares_owned_after":243693.0,"shares_owned_after_display":"243,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":6369199,"accession":"0001209191-18-045039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-045039","line_url":"/filing/0001209191-18-045039#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":19.5515,"price_display":"19.55","price_state":"stated","total_value":488767.9485,"total_display":"488,767.95","total_whole":"488,768","shares_owned_after":243693.0,"shares_owned_after_display":"243,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2018-08-02","scope":"insider"},{"id":6473976,"accession":"0001209191-18-041228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-041228","line_url":"/filing/0001209191-18-041228#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":15.4807,"price_display":"15.48","price_state":"stated","total_value":387002.0193,"total_display":"387,002.02","total_whole":"387,002","shares_owned_after":243693.0,"shares_owned_after_display":"243,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-02","filed_date":"2018-07-03","scope":"insider"},{"id":6862677,"accession":"0001209191-18-035876","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-035876","line_url":"/filing/0001209191-18-035876","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24999.0,"shares_display":"24,999","price_per_share":17.854954766190648,"price_display":"17.85","price_state":"stated","total_value":446356.0142,"total_display":"446,356.01","total_whole":"446,356","shares_owned_after":248492.0,"shares_owned_after_display":"248,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider","n_lines":2},{"id":2517633,"accession":"0001209191-16-153488","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-153488","line_url":"/filing/0001209191-16-153488","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3636.0,"shares_display":"3,636","price_per_share":22.775539713971398,"price_display":"22.78","price_state":"stated","total_value":82811.8624,"total_display":"82,811.86","total_whole":"82,812","shares_owned_after":242903.0,"shares_owned_after_display":"242,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider","n_lines":2},{"id":3298394,"accession":"0001209191-16-149937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-149937","line_url":"/filing/0001209191-16-149937#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.1839,"price_display":"30.18","price_state":"stated","total_value":301839.0,"total_display":"301,839.00","total_whole":"301,839","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-09","filed_date":"2016-11-14","scope":"insider"},{"id":3258379,"accession":"0001209191-16-145133","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-145133","line_url":"/filing/0001209191-16-145133","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":31.31518631,"price_display":"31.32","price_state":"stated","total_value":313151.8631,"total_display":"313,151.86","total_whole":"313,152","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider","n_lines":2},{"id":2325308,"accession":"0001209191-16-140254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-140254","line_url":"/filing/0001209191-16-140254#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.4949,"price_display":"32.49","price_state":"stated","total_value":324949.0,"total_display":"324,949.00","total_whole":"324,949","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-06","scope":"insider"},{"id":3128731,"accession":"0001209191-16-135308","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-135308","line_url":"/filing/0001209191-16-135308","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6426.0,"shares_display":"6,426","price_per_share":30.88458484282602,"price_display":"30.88","price_state":"stated","total_value":198464.3422,"total_display":"198,464.34","total_whole":"198,464","shares_owned_after":245806.0,"shares_owned_after_display":"245,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider","n_lines":2},{"id":3128723,"accession":"0001209191-16-135308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-135308","line_url":"/filing/0001209191-16-135308#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3574.0,"shares_display":"3,574","price_per_share":31.7526,"price_display":"31.75","price_state":"stated","total_value":113483.7924,"total_display":"113,483.79","total_whole":"113,484","shares_owned_after":242232.0,"shares_owned_after_display":"242,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":2926026,"accession":"0001209191-16-134343","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-134343","line_url":"/filing/0001209191-16-134343#line-4","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9187.0,"shares_display":"9,187","price_per_share":30.1538,"price_display":"30.15","price_state":"stated","total_value":277022.9606,"total_display":"277,022.96","total_whole":"277,023","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-27","filed_date":"2016-07-28","scope":"insider"},{"id":2926018,"accession":"0001209191-16-134343","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-134343","line_url":"/filing/0001209191-16-134343#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":813.0,"shares_display":"813","price_per_share":30.0026,"price_display":"30.00","price_state":"stated","total_value":24392.1138,"total_display":"24,392.11","total_whole":"24,392","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-26","filed_date":"2016-07-28","scope":"insider"},{"id":2179210,"accession":"0001209191-16-125838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-125838","line_url":"/filing/0001209191-16-125838#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0216,"price_display":"30.02","price_state":"stated","total_value":300216.0,"total_display":"300,216.00","total_whole":"300,216","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-03","scope":"insider"},{"id":2249380,"accession":"0001209191-16-124854","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-124854","line_url":"/filing/0001209191-16-124854#line-5","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33599.0,"shares_display":"33,599","price_per_share":30.0391,"price_display":"30.04","price_state":"stated","total_value":1009283.7209,"total_display":"1,009,283.72","total_whole":"1,009,284","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-01","scope":"insider"},{"id":2249366,"accession":"0001209191-16-124854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-124854","line_url":"/filing/0001209191-16-124854#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6401.0,"shares_display":"6,401","price_per_share":30.0477,"price_display":"30.05","price_state":"stated","total_value":192335.3277,"total_display":"192,335.33","total_whole":"192,335","shares_owned_after":242200.0,"shares_owned_after_display":"242,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-27","filed_date":"2016-06-01","scope":"insider"},{"id":2274693,"accession":"0001209191-16-090201","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-090201","line_url":"/filing/0001209191-16-090201","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":31.413695,"price_display":"31.41","price_state":"stated","total_value":314136.95,"total_display":"314,136.95","total_whole":"314,137","shares_owned_after":245226.0,"shares_owned_after_display":"245,226","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider","n_lines":2},{"id":8146667,"accession":"0001209191-15-083418","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-083418","line_url":"/filing/0001209191-15-083418#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4550.0,"shares_display":"4,550","price_per_share":37.2422,"price_display":"37.24","price_state":"stated","total_value":169452.01,"total_display":"169,452.01","total_whole":"169,452","shares_owned_after":241726.0,"shares_owned_after_display":"241,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8812980,"accession":"0001209191-15-078577","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-078577","line_url":"/filing/0001209191-15-078577","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":33.693532343234324,"price_display":"33.69","price_state":"stated","total_value":153137.1045,"total_display":"153,137.10","total_whole":"153,137","shares_owned_after":241265.0,"shares_owned_after_display":"241,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-02","filed_date":"2015-11-04","scope":"insider","n_lines":3},{"id":8302036,"accession":"0001209191-15-074112","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-074112","line_url":"/filing/0001209191-15-074112","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":32.25579130913091,"price_display":"32.26","price_state":"stated","total_value":146602.5715,"total_display":"146,602.57","total_whole":"146,603","shares_owned_after":241510.0,"shares_owned_after_display":"241,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-05","scope":"insider","n_lines":2},{"id":8727172,"accession":"0001209191-15-069524","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-069524","line_url":"/filing/0001209191-15-069524","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":38.51672673267327,"price_display":"38.52","price_state":"stated","total_value":175058.523,"total_display":"175,058.52","total_whole":"175,059","shares_owned_after":210347.0,"shares_owned_after_display":"210,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-01","filed_date":"2015-09-03","scope":"insider","n_lines":2},{"id":8139636,"accession":"0001209191-15-064182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-064182","line_url":"/filing/0001209191-15-064182#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":45.6155,"price_display":"45.62","price_state":"stated","total_value":207322.4475,"total_display":"207,322.45","total_whole":"207,322","shares_owned_after":209447.0,"shares_owned_after_display":"209,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8803115,"accession":"0001209191-15-059679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-059679","line_url":"/filing/0001209191-15-059679#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":51.129,"price_display":"51.13","price_state":"stated","total_value":232381.305,"total_display":"232,381.30","total_whole":"232,381","shares_owned_after":209447.0,"shares_owned_after_display":"209,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-06","scope":"insider"},{"id":8461205,"accession":"0001209191-15-051172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-051172","line_url":"/filing/0001209191-15-051172#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":44.1785,"price_display":"44.18","price_state":"stated","total_value":1104462.5,"total_display":"1,104,462.50","total_whole":"1,104,463","shares_owned_after":209447.0,"shares_owned_after_display":"209,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-04","filed_date":"2015-06-08","scope":"insider"},{"id":8925815,"accession":"0001209191-15-049865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-049865","line_url":"/filing/0001209191-15-049865#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":41.5306,"price_display":"41.53","price_state":"stated","total_value":188756.577,"total_display":"188,756.58","total_whole":"188,757","shares_owned_after":209447.0,"shares_owned_after_display":"209,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8925333,"accession":"0001209191-15-039050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-039050","line_url":"/filing/0001209191-15-039050#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":25.6684,"price_display":"25.67","price_state":"stated","total_value":116662.878,"total_display":"116,662.88","total_whole":"116,663","shares_owned_after":208988.0,"shares_owned_after_display":"208,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-01","filed_date":"2015-05-05","scope":"insider"},{"id":8670038,"accession":"0001209191-15-030980","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-030980","line_url":"/filing/0001209191-15-030980#line-4","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":27.4168,"price_display":"27.42","price_state":"stated","total_value":124609.356,"total_display":"124,609.36","total_whole":"124,609","shares_owned_after":208988.0,"shares_owned_after_display":"208,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-01","filed_date":"2015-04-01","scope":"insider"},{"id":8670034,"accession":"0001209191-15-030980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-030980","line_url":"/filing/0001209191-15-030980#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":30.2006,"price_display":"30.20","price_state":"stated","total_value":437908.7,"total_display":"437,908.70","total_whole":"437,909","shares_owned_after":208988.0,"shares_owned_after_display":"208,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-30","filed_date":"2015-04-01","scope":"insider"},{"id":8293066,"accession":"0001209191-15-022389","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-022389","line_url":"/filing/0001209191-15-022389#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4545.0,"shares_display":"4,545","price_per_share":26.2575,"price_display":"26.26","price_state":"stated","total_value":119340.3375,"total_display":"119,340.34","total_whole":"119,340","shares_owned_after":208988.0,"shares_owned_after_display":"208,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-02","filed_date":"2015-03-04","scope":"insider"},{"id":8481825,"accession":"0001209191-15-007127","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-007127","line_url":"/filing/0001209191-15-007127#line-4","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7145.0,"shares_display":"7,145","price_per_share":28.7303,"price_display":"28.73","price_state":"stated","total_value":205277.9935,"total_display":"205,277.99","total_whole":"205,278","shares_owned_after":208988.0,"shares_owned_after_display":"208,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-27","filed_date":"2015-01-28","scope":"insider"},{"id":8481817,"accession":"0001209191-15-007127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-007127","line_url":"/filing/0001209191-15-007127#line-2","is_derivative":false,"issuer_cik":"0001423824","issuer_name":"ALDER BIOPHARMACEUTICALS INC","issuer_ticker":"ALDR","issuer_name_source":null,"issuer_url":"/issuer/0001423824","owner_cik":"0001604874","owner_name":"Latham John A","owner_display_name":"Latham John A","owner_url":"/insider/0001604874","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7900.0,"shares_display":"7,900","price_per_share":27.9757,"price_display":"27.98","price_state":"stated","total_value":221008.03,"total_display":"221,008.03","total_whole":"221,008","shares_owned_after":208988.0,"shares_owned_after_display":"208,988","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-26","filed_date":"2015-01-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":43,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":43,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":43},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001423824","name":"ALDER BIOPHARMACEUTICALS INC","url":"/issuer/0001423824","role":"Officer (Chief Scientific Officer)","n_filings":27,"first_seen":"2015-01-28","last_seen":"2018-11-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001604874","retrieved_at":"2026-08-23T22:34:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}